Drug Type Small molecule drug |
Synonyms AccuSite, Fluorouracil/epinephrine, MPI 5003 + [1] |
Action inhibitors, agonists |
Mechanism TYMS inhibitors(Thymidylate synthase inhibitors), adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date- |
Regulation- |
Molecular FormulaC4H3FN2O2 |
InChIKeyGHASVSINZRGABV-UHFFFAOYSA-N |
CAS Registry51-21-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Human Papillomavirus Infection | Belgium | - | |
Human Papillomavirus Infection | Denmark | - | |
Human Papillomavirus Infection | Finland | - | |
Human Papillomavirus Infection | Germany | - | - |
Human Papillomavirus Infection | Ireland | - | |
Human Papillomavirus Infection | Italy | - | |
Human Papillomavirus Infection | Luxembourg | - | |
Human Papillomavirus Infection | Netherlands | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Basal Cell Carcinoma | Phase 3 | United States | - | - |
Basal Cell Carcinoma | Phase 3 | European Union | - | - |
Basal Cell Carcinoma | Phase 3 | Australia | - | |
Basal Cell Carcinoma | Phase 3 | Canada | - | |
Basal Cell Carcinoma | Phase 3 | New Zealand | - | |
Kaposi Sarcoma | Phase 2 | United Kingdom | - | |
Psoriasis | Phase 2 | United States | - | - |
Squamous Cell Carcinoma | Phase 2 | United States | - | - |
Squamous Cell Carcinoma | Phase 2 | Australia | - |